The store will not work correctly when cookies are disabled.
4-(2-Furyl)-3,4-dihydrobenzo[h]quinoline-2,5,6(1H)-trione
ID: ALA4782588
PubChem CID: 162664183
Max Phase: Preclinical
Molecular Formula: C17H11NO4
Molecular Weight: 293.28
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1CC(c2ccco2)C2=C(N1)c1ccccc1C(=O)C2=O
Standard InChI: InChI=1S/C17H11NO4/c19-13-8-11(12-6-3-7-22-12)14-15(18-13)9-4-1-2-5-10(9)16(20)17(14)21/h1-7,11H,8H2,(H,18,19)
Standard InChI Key: NMYYFAYVDCBNGC-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
28.6302 -2.3053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9173 -1.8912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6313 -3.1266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9171 -3.5369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9174 -4.3565 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.6301 -4.7721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3402 -4.3577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3416 -3.5319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2109 -3.1284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2115 -2.3089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5026 -1.8984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7927 -2.3104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7961 -3.1330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5055 -3.5357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6293 -5.5934 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.3378 -1.8924 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.9139 -1.0699 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.0452 -3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7923 -3.4543 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.3381 -2.8461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9282 -2.1391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1292 -2.3105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10 2 1 0
9 4 1 0
3 1 1 0
1 2 1 0
3 4 2 0
3 8 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
6 15 2 0
1 16 2 0
2 17 2 0
18 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 18 2 0
8 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 293.28 | Molecular Weight (Monoisotopic): 293.0688 | AlogP: 2.06 | #Rotatable Bonds: 1 |
Polar Surface Area: 76.38 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.55 | CX Basic pKa: ┄ | CX LogP: 1.23 | CX LogD: 1.23 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.82 | Np Likeness Score: -0.02 |
References
1. Wu LQ,Ma X,Zhang C,Liu ZP. (2020) Design, synthesis, and biological evaluation of 4-substituted-3,4-dihydrobenzo[h]quinoline-2,5,6(1H)-triones as NQO1-directed antitumor agents., 198 [PMID:32464425] [10.1016/j.ejmech.2020.112396] |